Skarping, Ida http://orcid.org/0000-0002-1265-8649
Förnvik, Daniel http://orcid.org/0000-0001-5083-7624
Zackrisson, Sophia http://orcid.org/0000-0001-5678-3882
Borgquist, Signe http://orcid.org/0000-0001-7938-8893
Rydén, Lisa http://orcid.org/0000-0001-7515-3130
Funding for this research was provided by:
Swedish Breast Cancer Group
Familjen Erling-Perssons Stiftelse
Governmental Funding of Clinical Research within National Health Services, Sweden
Lund University
Article History
Received: 27 January 2021
Accepted: 1 June 2021
First Online: 12 June 2021
Declarations
:
: SZ has received speakers’ fees and travel support from Siemens Healthcare AG, and consultancy fees from Collective Minds Radiology AB. SB has received speakers’ fees from Pfizer, is a study-specific advisor Pfizer, and has received travel support from Roche. The other authors declare that they have no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee in Lund, Sweden (Official records number: 2014/13, 2014/521 and 2016/521).
: Informed written consent was obtained from all participants included in the study.
: Consent for publication was obtained from all participants included in the study.